dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs3025039
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr6:43784799 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- C>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
T=0.134463 (35591/264690, TOPMED)T=0.140742 (25463/180920, ALFA)T=0.128842 (18017/139838, GnomAD) (+ 19 more)
- Clinical Significance
- Not Reported in ClinVar
- Gene : Consequence
-
POLR1C : Intron VariantVEGFA : 3 Prime UTR Variant
- Publications
- 229 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Release Version: 20230706150541
| Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|
| Total | Global | 181014 | C=0.859271 | T=0.140729 |
| European | Sub | 153472 | C=0.860945 | T=0.139055 |
| African | Sub | 9714 | C=0.9101 | T=0.0899 |
| African Others | Sub | 322 | C=0.907 | T=0.093 |
| African American | Sub | 9392 | C=0.9102 | T=0.0898 |
| Asian | Sub | 656 | C=0.841 | T=0.159 |
| East Asian | Sub | 524 | C=0.840 | T=0.160 |
| Other Asian | Sub | 132 | C=0.848 | T=0.152 |
| Latin American 1 | Sub | 738 | C=0.867 | T=0.133 |
| Latin American 2 | Sub | 6272 | C=0.7403 | T=0.2597 |
| South Asian | Sub | 190 | C=0.921 | T=0.079 |
| Other | Sub | 9972 | C=0.8582 | T=0.1418 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| TopMed | Global | Study-wide | 264690 | C=0.865537 | T=0.134463 |
| Allele Frequency Aggregator | Total | Global | 180920 | C=0.859258 | T=0.140742 |
| Allele Frequency Aggregator | European | Sub | 153396 | C=0.860922 | T=0.139078 |
| Allele Frequency Aggregator | Other | Sub | 9954 | C=0.8583 | T=0.1417 |
| Allele Frequency Aggregator | African | Sub | 9714 | C=0.9101 | T=0.0899 |
| Allele Frequency Aggregator | Latin American 2 | Sub | 6272 | C=0.7403 | T=0.2597 |
| Allele Frequency Aggregator | Latin American 1 | Sub | 738 | C=0.867 | T=0.133 |
| Allele Frequency Aggregator | Asian | Sub | 656 | C=0.841 | T=0.159 |
| Allele Frequency Aggregator | South Asian | Sub | 190 | C=0.921 | T=0.079 |
| gnomAD - Genomes | Global | Study-wide | 139838 | C=0.871158 | T=0.128842 |
| gnomAD - Genomes | European | Sub | 75744 | C=0.85728 | T=0.14272 |
| gnomAD - Genomes | African | Sub | 41914 | C=0.91437 | T=0.08563 |
| gnomAD - Genomes | American | Sub | 13606 | C=0.82669 | T=0.17331 |
| gnomAD - Genomes | Ashkenazi Jewish | Sub | 3318 | C=0.8686 | T=0.1314 |
| gnomAD - Genomes | East Asian | Sub | 3116 | C=0.8264 | T=0.1736 |
| gnomAD - Genomes | Other | Sub | 2140 | C=0.8678 | T=0.1322 |
| The PAGE Study | Global | Study-wide | 78700 | C=0.85673 | T=0.14327 |
| The PAGE Study | AfricanAmerican | Sub | 32514 | C=0.91653 | T=0.08347 |
| The PAGE Study | Mexican | Sub | 10810 | C=0.73145 | T=0.26855 |
| The PAGE Study | Asian | Sub | 8318 | C=0.8104 | T=0.1896 |
| The PAGE Study | PuertoRican | Sub | 7918 | C=0.8568 | T=0.1432 |
| The PAGE Study | NativeHawaiian | Sub | 4534 | C=0.8593 | T=0.1407 |
| The PAGE Study | Cuban | Sub | 4230 | C=0.8600 | T=0.1400 |
| The PAGE Study | Dominican | Sub | 3828 | C=0.8892 | T=0.1108 |
| The PAGE Study | CentralAmerican | Sub | 2450 | C=0.7792 | T=0.2208 |
| The PAGE Study | SouthAmerican | Sub | 1982 | C=0.7563 | T=0.2437 |
| The PAGE Study | NativeAmerican | Sub | 1260 | C=0.8397 | T=0.1603 |
| The PAGE Study | SouthAsian | Sub | 856 | C=0.922 | T=0.078 |
| 14KJPN | JAPANESE | Study-wide | 28258 | C=0.80303 | T=0.19697 |
| 8.3KJPN | JAPANESE | Study-wide | 16760 | C=0.80095 | T=0.19905 |
| 1000Genomes_30x | Global | Study-wide | 6404 | C=0.8660 | T=0.1340 |
| 1000Genomes_30x | African | Sub | 1786 | C=0.9177 | T=0.0823 |
| 1000Genomes_30x | Europe | Sub | 1266 | C=0.8728 | T=0.1272 |
| 1000Genomes_30x | South Asian | Sub | 1202 | C=0.8952 | T=0.1048 |
| 1000Genomes_30x | East Asian | Sub | 1170 | C=0.8248 | T=0.1752 |
| 1000Genomes_30x | American | Sub | 980 | C=0.777 | T=0.223 |
| 1000Genomes | Global | Study-wide | 5008 | C=0.8664 | T=0.1336 |
| 1000Genomes | African | Sub | 1322 | C=0.9160 | T=0.0840 |
| 1000Genomes | East Asian | Sub | 1008 | C=0.8304 | T=0.1696 |
| 1000Genomes | Europe | Sub | 1006 | C=0.8787 | T=0.1213 |
| 1000Genomes | South Asian | Sub | 978 | C=0.891 | T=0.109 |
| 1000Genomes | American | Sub | 694 | C=0.772 | T=0.228 |
| Genetic variation in the Estonian population | Estonian | Study-wide | 4480 | C=0.8339 | T=0.1661 |
| The Avon Longitudinal Study of Parents and Children | PARENT AND CHILD COHORT | Study-wide | 3854 | C=0.8661 | T=0.1339 |
| UK 10K study - Twins | TWIN COHORT | Study-wide | 3708 | C=0.8590 | T=0.1410 |
| KOREAN population from KRGDB | KOREAN | Study-wide | 2928 | C=0.8101 | T=0.1899 |
| Korean Genome Project | KOREAN | Study-wide | 1832 | C=0.8117 | T=0.1883 |
| CNV burdens in cranial meningiomas | Global | Study-wide | 790 | C=0.827 | T=0.173 |
| CNV burdens in cranial meningiomas | CRM | Sub | 790 | C=0.827 | T=0.173 |
| Northern Sweden | ACPOP | Study-wide | 600 | C=0.857 | T=0.143 |
| Medical Genome Project healthy controls from Spanish population | Spanish controls | Study-wide | 534 | C=0.858 | T=0.142 |
| Qatari | Global | Study-wide | 216 | C=0.889 | T=0.111 |
| A Vietnamese Genetic Variation Database | Global | Study-wide | 214 | C=0.846 | T=0.154 |
| SGDP_PRJ | Global | Study-wide | 146 | C=0.432 | T=0.568 |
| Ancient Sardinia genome-wide 1240k capture data generation and analysis | Global | Study-wide | 82 | C=0.83 | T=0.17 |
| The Danish reference pan genome | Danish | Study-wide | 40 | C=0.85 | T=0.15 |
| Siberian | Global | Study-wide | 12 | C=0.42 | T=0.58 |
Help
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Genomic Placements
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 6 | NC_000006.12:g.43784799C>T |
| GRCh37.p13 chr 6 | NC_000006.11:g.43752536C>T |
| VEGFA RefSeqGene | NG_008732.1:g.19584C>T |
Gene: POLR1C, RNA polymerase I and III subunit C
(plus strand)
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| POLR1C transcript variant 2 |
NM_001318876.2:c.945+2555… NM_001318876.2:c.945+255528C>T |
N/A | Intron Variant |
| POLR1C transcript variant 3 | NM_001363658.2:c. | N/A | Genic Downstream Transcript Variant |
| POLR1C transcript variant 1 | NM_203290.4:c. | N/A | Genic Downstream Transcript Variant |
| POLR1C transcript variant X1 | XM_047419577.1:c. | N/A | Genic Downstream Transcript Variant |
Gene: VEGFA, vascular endothelial growth factor A
(plus strand)
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| VEGFA transcript variant 4 | NM_001317010.1:c.*171= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 3 | NM_001025367.3:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 5 | NM_001025369.3:c.*253= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 7 | NM_001033756.3:c.*171= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 2 | NM_003376.6:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 8 | NM_001171622.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 6 | NM_001025370.3:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 10 | NM_001287044.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 9 | NM_001204385.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 4 | NM_001025368.3:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 1 | NM_001025366.3:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 3 | NM_001171625.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 9 | NM_001204384.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 4 | NM_001171626.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 6 | NM_001171628.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 8 | NM_001171630.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 2 | NM_001171624.2:c.*237= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 5 | NM_001171627.2:c.*253= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 7 | NM_001171629.2:c.*171= | N/A | 3 Prime UTR Variant |
| VEGFA transcript variant 1 | NM_001171623.2:c.*237= | N/A | 3 Prime UTR Variant |
Help
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Not Reported in ClinVar
Help
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | C= | T |
|---|---|---|
| GRCh38.p14 chr 6 | NC_000006.12:g.43784799= | NC_000006.12:g.43784799C>T |
| GRCh37.p13 chr 6 | NC_000006.11:g.43752536= | NC_000006.11:g.43752536C>T |
| VEGFA RefSeqGene | NG_008732.1:g.19584= | NG_008732.1:g.19584C>T |
| VEGFA transcript variant 2 | NM_003376.6:c.*237= | NM_003376.6:c.*237C>T |
| VEGFA transcript variant 2 | NM_003376.5:c.*237= | NM_003376.5:c.*237C>T |
| VEGFA transcript variant 1 | NM_001025366.3:c.*237= | NM_001025366.3:c.*237C>T |
| VEGFA transcript variant 1 | NM_001025366.2:c.*237= | NM_001025366.2:c.*237C>T |
| VEGFA transcript variant 3 | NM_001025367.3:c.*237= | NM_001025367.3:c.*237C>T |
| VEGFA transcript variant 3 | NM_001025367.2:c.*237= | NM_001025367.2:c.*237C>T |
| VEGFA transcript variant 4 | NM_001025368.3:c.*237= | NM_001025368.3:c.*237C>T |
| VEGFA transcript variant 4 | NM_001025368.2:c.*237= | NM_001025368.2:c.*237C>T |
| VEGFA transcript variant 5 | NM_001025369.3:c.*253= | NM_001025369.3:c.*253C>T |
| VEGFA transcript variant 5 | NM_001025369.2:c.*253= | NM_001025369.2:c.*253C>T |
| VEGFA transcript variant 7 | NM_001033756.3:c.*171= | NM_001033756.3:c.*171C>T |
| VEGFA transcript variant 7 | NM_001033756.2:c.*171= | NM_001033756.2:c.*171C>T |
| VEGFA transcript variant 6 | NM_001025370.3:c.*237= | NM_001025370.3:c.*237C>T |
| VEGFA transcript variant 6 | NM_001025370.2:c.*237= | NM_001025370.2:c.*237C>T |
| VEGFA transcript variant 1 | NM_001171623.2:c.*237= | NM_001171623.2:c.*237C>T |
| VEGFA transcript variant 1 | NM_001171623.1:c.*237= | NM_001171623.1:c.*237C>T |
| VEGFA transcript variant 2 | NM_001171624.2:c.*237= | NM_001171624.2:c.*237C>T |
| VEGFA transcript variant 2 | NM_001171624.1:c.*237= | NM_001171624.1:c.*237C>T |
| VEGFA transcript variant 3 | NM_001171625.2:c.*237= | NM_001171625.2:c.*237C>T |
| VEGFA transcript variant 3 | NM_001171625.1:c.*237= | NM_001171625.1:c.*237C>T |
| VEGFA transcript variant 4 | NM_001171626.2:c.*237= | NM_001171626.2:c.*237C>T |
| VEGFA transcript variant 4 | NM_001171626.1:c.*237= | NM_001171626.1:c.*237C>T |
| VEGFA transcript variant 5 | NM_001171627.2:c.*253= | NM_001171627.2:c.*253C>T |
| VEGFA transcript variant 5 | NM_001171627.1:c.*253= | NM_001171627.1:c.*253C>T |
| VEGFA transcript variant 9 | NM_001204385.2:c.*237= | NM_001204385.2:c.*237C>T |
| VEGFA transcript variant 9 | NM_001204385.1:c.*237= | NM_001204385.1:c.*237C>T |
| VEGFA transcript variant 9 | NM_001204384.2:c.*237= | NM_001204384.2:c.*237C>T |
| VEGFA transcript variant 9 | NM_001204384.1:c.*237= | NM_001204384.1:c.*237C>T |
| VEGFA transcript variant 7 | NM_001171629.2:c.*171= | NM_001171629.2:c.*171C>T |
| VEGFA transcript variant 7 | NM_001171629.1:c.*171= | NM_001171629.1:c.*171C>T |
| VEGFA transcript variant 6 | NM_001171628.2:c.*237= | NM_001171628.2:c.*237C>T |
| VEGFA transcript variant 6 | NM_001171628.1:c.*237= | NM_001171628.1:c.*237C>T |
| VEGFA transcript variant 8 | NM_001171630.2:c.*237= | NM_001171630.2:c.*237C>T |
| VEGFA transcript variant 8 | NM_001171630.1:c.*237= | NM_001171630.1:c.*237C>T |
| VEGFA transcript variant 8 | NM_001171622.2:c.*237= | NM_001171622.2:c.*237C>T |
| VEGFA transcript variant 8 | NM_001171622.1:c.*237= | NM_001171622.1:c.*237C>T |
| VEGFA transcript variant 10 | NM_001287044.2:c.*237= | NM_001287044.2:c.*237C>T |
| VEGFA transcript variant 10 | NM_001287044.1:c.*237= | NM_001287044.1:c.*237C>T |
| VEGFA transcript variant 4 | NM_001317010.1:c.*171= | NM_001317010.1:c.*171C>T |
| POLR1C transcript variant 2 | NM_001318876.2:c.945+255528= | NM_001318876.2:c.945+255528C>T |
Help
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
127 SubSNP,
22 Frequency
submissions
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | PGA-UW-FHCRC | ss4251017 | Jan 05, 2002 (102) |
| 2 | WI_SSAHASNP | ss6497123 | Feb 20, 2003 (111) |
| 3 | SNP500CANCER | ss6903975 | Mar 31, 2003 (113) |
| 4 | HGBASE | ss16383859 | Feb 28, 2004 (126) |
| 5 | ABI | ss44700568 | Mar 14, 2006 (126) |
| 6 | PGA-UW-FHCRC | ss52089132 | Oct 16, 2006 (127) |
| 7 | SHGC | ss68074563 | Nov 30, 2006 (127) |
| 8 | 1000GENOMES | ss110031387 | Jan 24, 2009 (130) |
| 9 | 1000GENOMES | ss114288283 | Jan 25, 2009 (130) |
| 10 | ILLUMINA | ss160607587 | Dec 01, 2009 (131) |
| 11 | COMPLETE_GENOMICS | ss166585665 | Jul 04, 2010 (132) |
| 12 | ILLUMINA | ss168911967 | Jul 04, 2010 (132) |
| 13 | ILLUMINA | ss173554751 | Jul 04, 2010 (132) |
| 14 | 1000GENOMES | ss222363733 | Jul 14, 2010 (132) |
| 15 | 1000GENOMES | ss233450745 | Jul 14, 2010 (132) |
| 16 | 1000GENOMES | ss240512373 | Jul 15, 2010 (132) |
| 17 | ILLUMINA | ss244293403 | Jul 04, 2010 (132) |
| 18 | ILLUMINA | ss480743812 | May 04, 2012 (137) |
| 19 | ILLUMINA | ss480759644 | May 04, 2012 (137) |
| 20 | ILLUMINA | ss481644807 | Sep 08, 2015 (146) |
| 21 | ILLUMINA | ss483709297 | May 04, 2012 (137) |
| 22 | ILLUMINA | ss485166657 | May 04, 2012 (137) |
| 23 | ILLUMINA | ss485246782 | May 04, 2012 (137) |
| 24 | ILLUMINA | ss537158428 | Sep 08, 2015 (146) |
| 25 | TISHKOFF | ss559173827 | Apr 25, 2013 (138) |
| 26 | SSMP | ss653112758 | Apr 25, 2013 (138) |
| 27 | ILLUMINA | ss778887331 | Sep 08, 2015 (146) |
| 28 | ILLUMINA | ss780379211 | Sep 08, 2015 (146) |
| 29 | ILLUMINA | ss782298169 | Sep 08, 2015 (146) |
| 30 | ILLUMINA | ss783029554 | Sep 08, 2015 (146) |
| 31 | ILLUMINA | ss783989293 | Sep 08, 2015 (146) |
| 32 | ILLUMINA | ss832287163 | Sep 08, 2015 (146) |
| 33 | ILLUMINA | ss834348394 | Sep 08, 2015 (146) |
| 34 | ILLUMINA | ss835867538 | Sep 08, 2015 (146) |
| 35 | EVA-GONL | ss982876029 | Aug 21, 2014 (142) |
| 36 | JMKIDD_LAB | ss1073574624 | Aug 21, 2014 (142) |
| 37 | 1000GENOMES | ss1319918189 | Aug 21, 2014 (142) |
| 38 | DDI | ss1430705438 | Apr 01, 2015 (144) |
| 39 | EVA_GENOME_DK | ss1581651195 | Apr 01, 2015 (144) |
| 40 | EVA_DECODE | ss1592412238 | Apr 01, 2015 (144) |
| 41 | EVA_UK10K_ALSPAC | ss1615469029 | Apr 01, 2015 (144) |
| 42 | EVA_UK10K_TWINSUK | ss1658463062 | Apr 01, 2015 (144) |
| 43 | EVA_MGP | ss1711130536 | Apr 01, 2015 (144) |
| 44 | ILLUMINA | ss1752638150 | Sep 08, 2015 (146) |
| 45 | WEILL_CORNELL_DGM | ss1926132285 | Feb 12, 2016 (147) |
| 46 | ILLUMINA | ss1958906372 | Feb 12, 2016 (147) |
| 47 | GENOMED | ss1970384462 | Jul 19, 2016 (147) |
| 48 | JJLAB | ss2023705654 | Sep 14, 2016 (149) |
| 49 | ILLUMINA | ss2094827760 | Dec 20, 2016 (150) |
| 50 | ILLUMINA | ss2095183449 | Dec 20, 2016 (150) |
| 51 | USC_VALOUEV | ss2151884173 | Dec 20, 2016 (150) |
| 52 | HUMAN_LONGEVITY | ss2283646296 | Dec 20, 2016 (150) |
| 53 | ILLUMINA | ss2634447150 | Nov 08, 2017 (151) |
| 54 | ILLUMINA | ss2634447151 | Nov 08, 2017 (151) |
| 55 | ILLUMINA | ss2634447152 | Nov 08, 2017 (151) |
| 56 | ILLUMINA | ss2634447153 | Nov 08, 2017 (151) |
| 57 | ILLUMINA | ss2635156982 | Nov 08, 2017 (151) |
| 58 | GRF | ss2707483075 | Nov 08, 2017 (151) |
| 59 | GNOMAD | ss2838403502 | Nov 08, 2017 (151) |
| 60 | AFFY | ss2985368725 | Nov 08, 2017 (151) |
| 61 | AFFY | ss2986000088 | Nov 08, 2017 (151) |
| 62 | SWEGEN | ss2998980197 | Nov 08, 2017 (151) |
| 63 | ILLUMINA | ss3022617718 | Nov 08, 2017 (151) |
| 64 | BIOINF_KMB_FNS_UNIBA | ss3025644010 | Nov 08, 2017 (151) |
| 65 | CSHL | ss3346938371 | Nov 08, 2017 (151) |
| 66 | ILLUMINA | ss3629537715 | Oct 12, 2018 (152) |
| 67 | ILLUMINA | ss3632364108 | Oct 12, 2018 (152) |
| 68 | ILLUMINA | ss3632364109 | Oct 12, 2018 (152) |
| 69 | ILLUMINA | ss3633420557 | Oct 12, 2018 (152) |
| 70 | ILLUMINA | ss3634143425 | Oct 12, 2018 (152) |
| 71 | ILLUMINA | ss3635066058 | Oct 12, 2018 (152) |
| 72 | ILLUMINA | ss3635824279 | Oct 12, 2018 (152) |
| 73 | ILLUMINA | ss3636788773 | Oct 12, 2018 (152) |
| 74 | ILLUMINA | ss3637577092 | Oct 12, 2018 (152) |
| 75 | ILLUMINA | ss3638628132 | Oct 12, 2018 (152) |
| 76 | ILLUMINA | ss3638628133 | Oct 12, 2018 (152) |
| 77 | ILLUMINA | ss3640773357 | Oct 12, 2018 (152) |
| 78 | ILLUMINA | ss3641194690 | Oct 12, 2018 (152) |
| 79 | ILLUMINA | ss3642487668 | Oct 12, 2018 (152) |
| 80 | ILLUMINA | ss3653134390 | Oct 12, 2018 (152) |
| 81 | ILLUMINA | ss3653134391 | Oct 12, 2018 (152) |
| 82 | ILLUMINA | ss3654134085 | Oct 12, 2018 (152) |
| 83 | EGCUT_WGS | ss3666871371 | Jul 13, 2019 (153) |
| 84 | EVA_DECODE | ss3717108827 | Jul 13, 2019 (153) |
| 85 | ILLUMINA | ss3726343992 | Jul 13, 2019 (153) |
| 86 | ACPOP | ss3733458801 | Jul 13, 2019 (153) |
| 87 | ILLUMINA | ss3744554615 | Jul 13, 2019 (153) |
| 88 | ILLUMINA | ss3745365997 | Jul 13, 2019 (153) |
| 89 | EVA | ss3764958112 | Jul 13, 2019 (153) |
| 90 | PAGE_CC | ss3771291361 | Jul 13, 2019 (153) |
| 91 | ILLUMINA | ss3772859559 | Jul 13, 2019 (153) |
| 92 | KHV_HUMAN_GENOMES | ss3808104508 | Jul 13, 2019 (153) |
| 93 | EVA | ss3825699929 | Apr 26, 2020 (154) |
| 94 | EVA | ss3829896972 | Apr 26, 2020 (154) |
| 95 | SGDP_PRJ | ss3864471881 | Apr 26, 2020 (154) |
| 96 | KRGDB | ss3911277602 | Apr 26, 2020 (154) |
| 97 | KOGIC | ss3958931525 | Apr 26, 2020 (154) |
| 98 | FSA-LAB | ss3984338429 | Apr 25, 2021 (155) |
| 99 | FSA-LAB | ss3984338430 | Apr 25, 2021 (155) |
| 100 | EVA | ss3984568624 | Apr 25, 2021 (155) |
| 101 | EVA | ss3985220866 | Apr 25, 2021 (155) |
| 102 | EVA | ss3986035967 | Apr 25, 2021 (155) |
| 103 | EVA | ss3986346342 | Apr 25, 2021 (155) |
| 104 | EVA | ss4017273194 | Apr 25, 2021 (155) |
| 105 | TOPMED | ss4701158714 | Apr 25, 2021 (155) |
| 106 | TOMMO_GENOMICS | ss5177269858 | Apr 25, 2021 (155) |
| 107 | EVA | ss5237398073 | Apr 25, 2021 (155) |
| 108 | 1000G_HIGH_COVERAGE | ss5268260815 | Oct 13, 2022 (156) |
| 109 | EVA | ss5315153548 | Oct 13, 2022 (156) |
| 110 | EVA | ss5365286595 | Oct 13, 2022 (156) |
| 111 | HUGCELL_USP | ss5465952086 | Oct 13, 2022 (156) |
| 112 | 1000G_HIGH_COVERAGE | ss5554061844 | Oct 13, 2022 (156) |
| 113 | EVA | ss5624157129 | Oct 13, 2022 (156) |
| 114 | SANFORD_IMAGENETICS | ss5624628727 | Oct 13, 2022 (156) |
| 115 | SANFORD_IMAGENETICS | ss5640295420 | Oct 13, 2022 (156) |
| 116 | TOMMO_GENOMICS | ss5715249598 | Oct 13, 2022 (156) |
| 117 | EVA | ss5799687920 | Oct 13, 2022 (156) |
| 118 | EVA | ss5800131626 | Oct 13, 2022 (156) |
| 119 | YY_MCH | ss5807422617 | Oct 13, 2022 (156) |
| 120 | EVA | ss5842170512 | Oct 13, 2022 (156) |
| 121 | EVA | ss5847294846 | Oct 13, 2022 (156) |
| 122 | EVA | ss5848096546 | Oct 13, 2022 (156) |
| 123 | EVA | ss5848659410 | Oct 13, 2022 (156) |
| 124 | EVA | ss5855336308 | Oct 13, 2022 (156) |
| 125 | EVA | ss5883603903 | Oct 13, 2022 (156) |
| 126 | EVA | ss5968791768 | Oct 13, 2022 (156) |
| 127 | EVA | ss5979786074 | Oct 13, 2022 (156) |
| 128 | 1000Genomes | NC_000006.11 - 43752536 | Oct 12, 2018 (152) |
| 129 | 1000Genomes_30x | NC_000006.12 - 43784799 | Oct 13, 2022 (156) |
| 130 | The Avon Longitudinal Study of Parents and Children | NC_000006.11 - 43752536 | Oct 12, 2018 (152) |
| 131 | Genetic variation in the Estonian population | NC_000006.11 - 43752536 | Oct 12, 2018 (152) |
| 132 | The Danish reference pan genome | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 133 | gnomAD - Genomes | NC_000006.12 - 43784799 | Apr 25, 2021 (155) |
| 134 | KOREAN population from KRGDB | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 135 | Korean Genome Project | NC_000006.12 - 43784799 | Apr 26, 2020 (154) |
| 136 | Medical Genome Project healthy controls from Spanish population | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 137 | Northern Sweden | NC_000006.11 - 43752536 | Jul 13, 2019 (153) |
| 138 | The PAGE Study | NC_000006.12 - 43784799 | Jul 13, 2019 (153) |
| 139 | Ancient Sardinia genome-wide 1240k capture data generation and analysis | NC_000006.11 - 43752536 | Apr 25, 2021 (155) |
| 140 | CNV burdens in cranial meningiomas | NC_000006.11 - 43752536 | Apr 25, 2021 (155) |
| 141 | Qatari | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 142 | SGDP_PRJ | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 143 | Siberian | NC_000006.11 - 43752536 | Apr 26, 2020 (154) |
| 144 | 8.3KJPN | NC_000006.11 - 43752536 | Apr 25, 2021 (155) |
| 145 | 14KJPN | NC_000006.12 - 43784799 | Oct 13, 2022 (156) |
| 146 | TopMed | NC_000006.12 - 43784799 | Apr 25, 2021 (155) |
| 147 | UK 10K study - Twins | NC_000006.11 - 43752536 | Oct 12, 2018 (152) |
| 148 | A Vietnamese Genetic Variation Database | NC_000006.11 - 43752536 | Jul 13, 2019 (153) |
| 149 | ALFA | NC_000006.12 - 43784799 | Apr 25, 2021 (155) |
Help
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
| Associated ID | History Updated (Build) |
|---|---|
| rs11575898 | Oct 25, 2006 (127) |
Added to this RefSNP Cluster:
| Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
|---|---|---|---|
| ss110031387, ss114288283, ss166585665, ss480743812, ss485246782, ss1592412238, ss2635156982 | NC_000006.10:43860513:C:T | NC_000006.12:43784798:C:T | (self) |
| 31699361, 17679111, 12609619, 7816134, 18454996, 246296, 6743666, 446793, 118032, 8174215, 16488861, 4400527, 35239165, 17679111, 3924041, ss222363733, ss233450745, ss240512373, ss480759644, ss481644807, ss483709297, ss485166657, ss537158428, ss559173827, ss653112758, ss778887331, ss780379211, ss782298169, ss783029554, ss783989293, ss832287163, ss834348394, ss835867538, ss982876029, ss1073574624, ss1319918189, ss1430705438, ss1581651195, ss1615469029, ss1658463062, ss1711130536, ss1752638150, ss1926132285, ss1958906372, ss1970384462, ss2023705654, ss2094827760, ss2095183449, ss2151884173, ss2634447150, ss2634447151, ss2634447152, ss2634447153, ss2707483075, ss2838403502, ss2985368725, ss2986000088, ss2998980197, ss3022617718, ss3346938371, ss3629537715, ss3632364108, ss3632364109, ss3633420557, ss3634143425, ss3635066058, ss3635824279, ss3636788773, ss3637577092, ss3638628132, ss3638628133, ss3640773357, ss3641194690, ss3642487668, ss3653134390, ss3653134391, ss3654134085, ss3666871371, ss3733458801, ss3744554615, ss3745365997, ss3764958112, ss3772859559, ss3825699929, ss3829896972, ss3864471881, ss3911277602, ss3984338429, ss3984338430, ss3984568624, ss3985220866, ss3986035967, ss3986346342, ss4017273194, ss5177269858, ss5237398073, ss5315153548, ss5365286595, ss5624157129, ss5624628727, ss5640295420, ss5799687920, ss5800131626, ss5842170512, ss5847294846, ss5848096546, ss5848659410, ss5968791768, ss5979786074 | NC_000006.11:43752535:C:T | NC_000006.12:43784798:C:T | (self) |
| 41587779, 223669264, 15309526, 512830, 49086702, 538536272, 5105400493, ss2283646296, ss3025644010, ss3717108827, ss3726343992, ss3771291361, ss3808104508, ss3958931525, ss4701158714, ss5268260815, ss5465952086, ss5554061844, ss5715249598, ss5807422617, ss5855336308, ss5883603903 | NC_000006.12:43784798:C:T | NC_000006.12:43784798:C:T | (self) |
| ss4251017, ss6497123, ss6903975, ss16383859, ss44700568, ss52089132, ss68074563, ss160607587, ss168911967, ss173554751, ss244293403 | NT_007592.15:43692535:C:T | NC_000006.12:43784798:C:T | (self) |
Help
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
229
citations for rs3025039
| PMID | Title | Author | Year | Journal |
|---|---|---|---|---|
| 15338501 | Vascular endothelial growth factor gene polymorphisms in Behçet's disease. | Salvarani C et al. | 2004 | The Journal of rheumatology |
| 16613616 | Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. | Jacobs EJ et al. | 2006 | Breast cancer research |
| 16645995 | Vascular endothelial growth factor gene haplotypes in Kawasaki disease. | Breunis WB et al. | 2006 | Arthritis and rheumatism |
| 17204151 | VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. | Butt C et al. | 2007 | BMC musculoskeletal disorders |
| 17319747 | Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. | García-Closas M et al. | 2007 | PLoS genetics |
| 17601350 | A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. | Harris SE et al. | 2007 | BMC genetics |
| 17983459 | Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. | Kim DH et al. | 2008 | British journal of haematology |
| 18281657 | VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. | Heist RS et al. | 2008 | Journal of clinical oncology |
| 18378209 | Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. | Lin JM et al. | 2008 | American journal of ophthalmology |
| 18650217 | Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. | Zhao ZZ et al. | 2008 | Molecular human reproduction |
| 18676870 | Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. | Hsing AW et al. | 2008 | Cancer research |
| 18780893 | Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. | Zhai R et al. | 2008 | Carcinogenesis |
| 18805939 | Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. | Tempfer CB et al. | 2009 | Human reproduction update |
| 19041064 | Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. | Kim DH et al. | 2008 | Biology of blood and marrow transplantation |
| 19089753 | Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. | Kangas-Kontio T et al. | 2009 | Scandinavian journal of clinical and laboratory investigation |
| 19196101 | Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. | Lin GT et al. | 2009 | Omics |
| 19372140 | EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. | Mason RA et al. | 2009 | Carcinogenesis |
| 19438866 | Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress and inflammatory response, and melanoma risk. | Gu F et al. | 2009 | The British journal of dermatology |
| 19496079 | Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. | Tahara T et al. | 2009 | Molecular carcinogenesis |
| 19566948 | Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. | Guan X et al. | 2009 | Journal of experimental & clinical cancer research |
| 19584152 | Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. | Bradbury PA et al. | 2009 | Clinical cancer research |
| 19594543 | Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. | Masago K et al. | 2009 | Cancer science |
| 19603096 | An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. | Dong LM et al. | 2009 | PloS one |
| 19622587 | Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. | Lurje G et al. | 2010 | Annals of oncology |
| 19628492 | Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. | Kangas-Kontio T et al. | 2009 | The British journal of ophthalmology |
| 19755511 | The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. | Jain L et al. | 2009 | Molecular cancer therapeutics |
| 19787077 | Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. | Lachheb J et al. | 2008 | Gene regulation and systems biology |
| 19835575 | The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. | Guan X et al. | 2009 | BMC gastroenterology |
| 19875757 | Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy. | Kim DH et al. | 2010 | Annals of oncology |
| 20019880 | Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. | Fang AM et al. | 2009 | Molecular vision |
| 20082870 | A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation. | Wu LM et al. | 2009 | Archives of medical research |
| 20124951 | Vascular endothelial growth factor pathway. | Maitland ML et al. | 2010 | Pharmacogenetics and genomics |
| 20357209 | Molecular genetic studies of gene identification for osteoporosis: the 2009 update. | Xu XH et al. | 2010 | Endocrine reviews |
| 20389299 | Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. | Xu CF et al. | 2010 | British journal of cancer |
| 20540786 | The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients. | Kim SJ et al. | 2010 | Journal of experimental & clinical cancer research |
| 20712888 | Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. | Guan X et al. | 2010 | BMC cancer |
| 20847577 | Vascular endothelial growth factor gene polymorphisms and risk of neovascular age-related macular degeneration in a Chinese cohort. | Qu Y et al. | 2011 | Ophthalmic research |
| 21080079 | Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population. | Yang JW et al. | 2011 | Molecular biology reports |
| 21119072 | Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. | Beeghly-Fadiel A et al. | 2011 | Cancer epidemiology, biomarkers & prevention |
| 21242666 | Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness. | Ding H et al. | 2011 | Respiration; international review of thoracic diseases |
| 21245770 | Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. | Lv HZ et al. | 2011 | Journal of investigative medicine |
| 21343546 | Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. | Argiris A et al. | 2011 | Journal of clinical oncology |
| 21347390 | Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. | Ruggiero D et al. | 2011 | PloS one |
| 21362767 | Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. | Chen Y et al. | 2011 | The Journal of rheumatology |
| 21407216 | Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. | Loupakis F et al. | 2011 | British journal of cancer |
| 21454829 | Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. | Zhang B et al. | 2011 | American journal of epidemiology |
| 21669012 | Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer. | Loupakis F et al. | 2011 | BMC cancer |
| 21706043 | Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. | Gong ZP et al. | 2011 | Acta pharmacologica Sinica |
| 21708280 | Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. | Srivastava K et al. | 2011 | Mutation research |
| 21757650 | Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. | Debette S et al. | 2011 | Circulation research |
| 21791631 | Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. | Gerger A et al. | 2011 | Clinical cancer research |
| 21882181 | Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. | Kim JJ et al. | 2012 | Cancer |
| 21982816 | Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population. | Al-Habboubi HH et al. | 2011 | European cytokine network |
| 22129133 | VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. | Kim MK et al. | 2012 | Cancer science |
| 22139971 | Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. | Andersen NF et al. | 2012 | International journal of cancer |
| 22162628 | Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. | Yang X et al. | 2011 | Molecular vision |
| 22295056 | Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. | Christie JD et al. | 2012 | PloS one |
| 22315135 | The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. | Rodrigues P et al. | 2012 | Breast cancer research and treatment |
| 22320189 | Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. | Yin M et al. | 2012 | Cancer science |
| 22429695 | Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. | Chen Y et al. | 2012 | Cytokine |
| 22439647 | The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. | Rutkowski P et al. | 2012 | BMC cancer |
| 22491902 | The interaction between the maternal BMI and angiogenic gene polymorphisms associates with the risk of spontaneous preterm birth. | Andraweera PH et al. | 2012 | Molecular human reproduction |
| 22521084 | Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. | Boltz A et al. | 2012 | Ophthalmology |
| 22678500 | Genetic factors for choroidal neovascularization associated with high myopia. | Leveziel N et al. | 2012 | Investigative ophthalmology & visual science |
| 22729570 | AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau. | Buroker NE et al. | 2012 | International journal of hematology |
| 22742663 | SNP-set analysis replicates acute lung injury genetic risk factors. | Meyer NJ et al. | 2012 | BMC medical genetics |
| 22776467 | Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes. | Chen Y et al. | 2012 | Clinical and experimental rheumatology |
| 22808003 | Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. | Scartozzi M et al. | 2012 | PloS one |
| 22818823 | Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. | Supic G et al. | 2012 | Oral oncology |
| 22925497 | The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. | Al-Habboubi HH et al. | 2012 | European journal of haematology |
| 23057767 | Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China. | Castro FA et al. | 2012 | BMC cancer |
| 23061744 | Association of the vascular endothelial growth factor gene polymorphisms (-460C/T, +405G/C and +936T/C) with endometriosis: a meta-analysis. | Xu S et al. | 2012 | Annals of human genetics |
| 23073296 | VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population. | Sáenz-López P et al. | 2013 | Human immunology |
| 23102494 | Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka. | Andraweera PH et al. | 2013 | The journal of maternal-fetal & neonatal medicine |
| 23155356 | VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. | Tamura T et al. | 2012 | International journal of medical sciences |
| 23211130 | Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage. | Li L et al. | 2013 | The journal of maternal-fetal & neonatal medicine |
| 23251429 | Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. | O'Mahony DS et al. | 2012 | PloS one |
| 23264084 | Positive association of the vascular endothelial growth factor-A +405 GG genotype and poor survival in stage I-II gastric cancer in the Northern Chinese population. | Li A et al. | 2013 | Molecular biology reports |
| 23545315 | Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility. | Cui QT et al. | 2013 | Gene |
| 23586368 | Vascular endothelial growth factor 936 c>T polymorphism increased oral cancer risk: evidence from a meta-analysis. | Mandal RK et al. | 2013 | Genetic testing and molecular biomarkers |
| 23625573 | A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. | Absenger G et al. | 2013 | Molecular carcinogenesis |
| 23644986 | Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran. | Kalmeh ZA et al. | 2013 | Molecular biology reports |
| 23848209 | Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis. | Zhang Y et al. | 2013 | Scandinavian journal of rheumatology |
| 23880405 | Methionine sulfoxide reductase A rs10903323 G/A polymorphism is associated with increased risk of coronary artery disease in a Chinese population. | Gu H et al. | 2013 | Clinical biochemistry |
| 23900206 | Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. | Almawi WY et al. | 2013 | Human reproduction (Oxford, England) |
| 23946381 | Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. | Ma X et al. | 2014 | Gut |
| 24057253 | VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis. | Zhao SF et al. | 2013 | Molecular biology reports |
| 24079541 | The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration. | Liutkeviciene R et al. | 2015 | Ophthalmic genetics |
| 24340057 | Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. | Liu H et al. | 2013 | PloS one |
| 24662923 | Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns. | Fujioka K et al. | 2014 | Scientific reports |
| 24689893 | Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration. | Liu Y et al. | 2014 | Genetic testing and molecular biomarkers |
| 24801045 | First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. | Prebil LA et al. | 2014 | Cancer causes & control |
| 24868559 | The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies. | Han L et al. | 2014 | Journal of diabetes research |
| 24895547 | Double-bottom chaotic map particle swarm optimization based on chi-square test to determine gene-gene interactions. | Yang CH et al. | 2014 | BioMed research international |
| 24940484 | Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk. | Yang Y et al. | 2014 | Molecular and clinical oncology |
| 24945674 | Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. | Yang PW et al. | 2014 | PloS one |
| 24971577 | Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia. | Lozano-Santos C et al. | 2014 | PloS one |
| 25214541 | A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. | Findlay JM et al. | 2015 | Annals of oncology |
| 25488616 | Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia. | Góra-Tybor J et al. | 2015 | Blood cells, molecules & diseases |
| 25541433 | Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians. | Zidi S et al. | 2015 | Cytokine |
| 25541696 | Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obstructive sleep apnea syndrome. | Cao C et al. | 2014 | PloS one |
| 25558172 | Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients. | Park UC et al. | 2014 | Molecular vision |
| 25617075 | Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer. | Sibertin-Blanc C et al. | 2015 | Digestive and liver disease |
| 25714003 | Association of VEGFA gene polymorphisms and VEGFA plasma levels with spontaneous preterm birth. | Langmia IM et al. | 2015 | Pharmacogenetics and genomics |
| 25894555 | Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis. | Xu X et al. | 2015 | PloS one |
| 25894981 | Genetic variations of VEGF gene were associated with tetralogy of fallot risk in a Chinese Han population. | Yan L et al. | 2015 | Genetic testing and molecular biomarkers |
| 25928231 | Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis. | Wang S et al. | 2015 | BMC medical genetics |
| 25956512 | Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy. | Choudhuri S et al. | 2015 | Molecular and cellular biochemistry |
| 25959001 | Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization. | Duran J et al. | 2015 | BMC cardiovascular disorders |
| 26086871 | Genetic association between VEGF polymorphisms and BRONJ in the Korean population. | Choi H et al. | 2015 | Oral diseases |
| 26093379 | Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study. | Zhang J et al. | 2016 | Molecular neurobiology |
| 26158818 | Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population. | Janardhan B et al. | 2015 | PloS one |
| 26264619 | Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers. | Bhaskari J et al. | 2016 | Tumour biology |
| 26330749 | Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration. | Ambreen F et al. | 2015 | Molecular vision |
| 26345918 | Vascular endothelial growth factor gene is associated with hypertensive cerebellar hemorrhage and rehabilitative treatment. | He QS et al. | 2015 | Genetics and molecular research |
| 26373931 | Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives. | Tomar A et al. | 2015 | BMC genetics |
| 26553067 | Association between a vascular endothelial growth factor gene polymorphism (rs2146323) and diabetic retinopathy: a meta-analysis. | Zeng Y et al. | 2015 | BMC ophthalmology |
| 26627480 | Genetic predisposition to acute kidney injury--a systematic review. | Vilander LM et al. | 2015 | BMC nephrology |
| 26648684 | Update on genetics and diabetic retinopathy. | Hampton BM et al. | 2015 | Clinical ophthalmology (Auckland, N.Z.) |
| 26701102 | Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma. | Yang SM et al. | 2015 | PloS one |
| 26825024 | VEGF Gene Polymorphisms Affect Serum Protein Levels and Alter Disease Activity and Synovial Lesions in Rheumatoid Arthritis. | Yi JP et al. | 2016 | Medical science monitor |
| 26870349 | Impact of single-nucleotide polymorphisms on radiation pneumonitis in cancer patients. | Guo CX et al. | 2016 | Molecular and clinical oncology |
| 26881237 | Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus. | Merlo S et al. | 2016 | Journal of diabetes research |
| 27116510 | Effect of Risk Alleles in CFH, C3, and VEGFA on the Response to Intravitreal Bevacizumab in Tunisian Patients with Neovascular Age-related Macular Degeneration. | Habibi I et al. | 2016 | Klinische Monatsblatter fur Augenheilkunde |
| 27117754 | Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients. | Giampieri R et al. | 2016 | Scientific reports |
| 27139155 | Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer. | Gampenrieder SP et al. | 2017 | The pharmacogenomics journal |
| 27163696 | Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population. | Baz-Dávila R et al. | 2016 | PloS one |
| 27175586 | Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma. | Bianconi M et al. | 2016 | Oncotarget |
| 27175642 | Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease. | Liu D et al. | 2016 | Medicine |
| 27334288 | No associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patients. | Dan LA et al. | 2016 | Cancer medicine |
| 27398026 | Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population. | Rezaei M et al. | 2016 | Breast cancer |
| 27425626 | EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension. | Mei M et al. | 2016 | Scientific reports |
| 27481110 | Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population. | Wu Y et al. | 2016 | Neurological sciences |
| 27613596 | Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta-analysis. | Xie XJ et al. | 2017 | Journal of diabetes |
| 27668980 | VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population. | Amosco MD et al. | 2016 | Clinical and experimental hypertension (New York, N.Y. |
| 27709850 | The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology. | Lee S et al. | 2016 | Journal of Korean medical science |
| 27730450 | Candidate gene studies of diabetic retinopathy in human. | Priščáková P et al. | 2016 | Molecular biology reports |
| 27766947 | Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population. | Ben Salem A et al. | 2016 | BMC genomics |
| 27846231 | Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome. | Almawi WY et al. | 2016 | PloS one |
| 27896475 | An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure. | Ravegnini G et al. | 2017 | Angiogenesis |
| 27897268 | Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. | Morgen EK et al. | 2017 | The pharmacogenomics journal |
| 27932624 | Allele rs2010963 C of the VEGFA gene is associated with the decreased risk of primary varicose veins in ethnic Russians. | Shadrina AS et al. | 2018 | Phlebology |
| 28117391 | Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib. | Cebrián A et al. | 2017 | Scientific reports |
| 28234972 | A functional variant in the 3'-UTR of VEGF predicts the 90-day outcome of ischemic stroke in Chinese patients. | Zhao J et al. | 2017 | PloS one |
| 28282525 | Association between vascular endothelial growth factor polymorphism and recurrent pregnancy loss: A systematic review and meta-analysis. | Sun Y et al. | 2017 | European journal of obstetrics, gynecology, and reproductive biology |
| 28328959 | KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer. | Yang M et al. | 2017 | PloS one |
| 28356760 | The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis. | Wang J et al. | 2017 | OncoTargets and therapy |
| 28373444 | bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients. | Wróbel T et al. | 2017 | Anticancer research |
| 28401369 | The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of Developing Multiple Sclerosis is Taken into Consideration. | Mazdeh M et al. | 2017 | Journal of molecular neuroscience |
| 28430629 | Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis. | Wang Y et al. | 2017 | Oncotarget |
| 28442515 | Genetic Polymorphisms rs699947, rs1570360, and rs3025039 on the VEGF Gene Are Correlated with Extracranial Internal Carotid Artery Stenosis and Ischemic Stroke. | Yadav BK et al. | 2017 | Annals of clinical and laboratory science |
| 28562357 | Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis. | Hou Q et al. | 2017 | Oncotarget |
| 28631700 | [Polymorphism in the regulatory regions -С2578A and +C936T of the vascular endothelial growth factor (VEGF-A) gene in Russian women with rheumatoid arthritis]. | Shevchenko AV et al. | 2017 | Terapevticheskii arkhiv |
| 28651127 | Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study. | Ben Ali Gannoun M et al. | 2017 | Cytokine |
| 28710035 | Association of common genetic variants in VEGFA with biliary atresia susceptibility in Northwestern Han Chinese. | Liu B et al. | 2017 | Gene |
| 28762915 | [Association of Serum Levels and Gene Polymorphism of Vascular Endothelium Growth Factor With Ischemic Heart Disease in Type 2 Diabetic Patients]. | Klimontov VV et al. | 2017 | Kardiologiia |
| 28770234 | SNPs, linkage disequilibrium, and chronic mountain sickness in Tibetan Chinese. | Buroker NE et al. | 2017 | Hypoxia (Auckland, N.Z.) |
| 29041886 | [Polymorphisms in Genes of Cytokines and Matrix Metalloproteinases Associated With Ischemic Heart Disease in Patients With Type 2 Diabetes]. | Klimontov VV et al. | 2017 | Kardiologiia |
| 29137376 | Impact of VEGFA polymorphisms on glioma risk in Chinese. | Zhao P et al. | 2017 | Oncotarget |
| 29251369 | Association of polymorphism in the VEGFA gene 3'-UTR +936T/C with susceptibility to biliary atresia in a Southern Chinese Han population. | Liu F et al. | 2018 | Journal of clinical laboratory analysis |
| 29364361 | Vascular endothelial growth factor gene variations as a risk predictor in disc degeneration. | Amaro A et al. | 2017 | Einstein (Sao Paulo, Brazil) |
| 29533820 | Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study. | Sellami N et al. | 2018 | Cytokine |
| 29700787 | Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration. | Lorés-Motta L et al. | 2018 | Molecular diagnosis & therapy |
| 29959793 | Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population. | Ben Wafi S et al. | 2018 | Journal of clinical laboratory analysis |
| 29973139 | Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis. | Ma WQ et al. | 2018 | BMC medical genetics |
| 29984822 | Single-nucleotide polymorphisms of VEGF-A and VEGFR-2 genes and risk of infantile hemangioma. | Oszajca K et al. | 2018 | International journal of dermatology |
| 30098261 | [Association of vascular endothelial growth factor gene polymorphisms with Crohn's disease among Chinese patients]. | Pei J et al. | 2018 | Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics |
| 30203425 | Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. | Cencini E et al. | 2019 | British journal of haematology |
| 30235774 | Systematic meta-analysis of genetic variants associated with osteosarcoma susceptibility. | Wang X et al. | 2018 | Medicine |
| 30317903 | Vascular endothelial growth factor gene polymorphisms and coronary heart disease: a systematic review and meta-analysis. | Zhao X et al. | 2018 | Growth factors (Chur, Switzerland) |
| 30350881 | Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus. | Dong PP et al. | 2019 | Journal of clinical laboratory analysis |
| 30391947 | Can Functional Polymorphisms in VEGF and MMP Predict Intraventricular Hemorrhage in Extremely Preterm Newborns? | Prasun P et al. | 2018 | Developmental neuroscience |
| 30409050 | An intron variant in the FLT1 gene increases the risk of preeclampsia in Iranian women. | Amin-Beidokhti M et al. | 2019 | Clinical and experimental hypertension (New York, N.Y. |
| 30551681 | Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer. | Furuya TK et al. | 2018 | Genes |
| 30609111 | VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants. | Zhang LF et al. | 2019 | Journal of cellular biochemistry |
| 30689460 | The roles of vascular endothelial growth factor gene polymorphisms in congenital heart diseases: a meta-analysis. | Wang W et al. | 2018 | Growth factors (Chur, Switzerland) |
| 30849545 | Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects. | Song Y et al. | 2019 | Gene |
| 30988702 | Defining the genetic profile of endometriosis. | Vassilopoulou L et al. | 2019 | Experimental and therapeutic medicine |
| 31032699 | Haplotype analysis of VEGF gene polymorphisms in polycystic ovary syndrome. | Gomes MKO et al. | 2019 | Gynecological endocrinology |
| 31177128 | Associations Between Gene Polymorphisms of Vascular Endothelial Growth Factor and Prostate Cancer. | Drobková H et al. | 2019 | Anticancer research |
| 31376092 | Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter. | Molinaro A et al. | 2020 | Journal of endocrinological investigation |
| 31385237 | Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients. | Bao L et al. | 2019 | Molecular biology reports |
| 31405022 | KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis. | Paradowska-Gorycka A et al. | 2019 | Biomolecules |
| 31445964 | Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. | Guo Z et al. | 2020 | International journal of oral and maxillofacial surgery |
| 31486735 | Gene polymorphisms in VEGFA and COL2A1 are associated with response to inhaled corticosteroids in children with asthma. | Wan Z et al. | 2019 | Pharmacogenomics |
| 31487639 | Vascular endothelial growth factor gene polymorphisms and hypertensive disorder of pregnancy: A meta-analysis. | Su M et al. | 2019 | Pregnancy hypertension |
| 31499478 | Association of the Vascular Endothelial Growth Factor Gene Polymorphism +936 C/T with Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus. | Arredondo-García VK et al. | 2019 | Archives of medical research |
| 31637880 | MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis. | Gholami M et al. | 2019 | Cancer medicine |
| 31646966 | MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. | Khidri FF et al. | 2019 | BMC medical genetics |
| 31821471 | Polymorphisms and endometriosis: a systematic review and meta-analyses. | Méar L et al. | 2020 | Human reproduction update |
| 31830994 | Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis. | Quan Y et al. | 2019 | World journal of surgical oncology |
| 31943890 | Association of VEGFA and IL1β gene polymorphisms with preeclampsia in Sudanese women. | Hamid HM et al. | 2020 | Molecular genetics & genomic medicine |
| 32003435 | Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk. | Huang L et al. | 2020 | Bioscience reports |
| 32014908 | Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma. | Psoma E et al. | 2020 | Anticancer research |
| 32152937 | Application of Artificial Neural Network for Prediction of Risk of Multiple Sclerosis Based on Single Nucleotide Polymorphism Genotypes. | Ghafouri-Fard S et al. | 2020 | Journal of molecular neuroscience |
| 32164758 | Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis. | Zhao J et al. | 2020 | Reproductive biology and endocrinology |
| 32255175 | A meta-analysis of the vascular endothelial growth factor polymorphisms associated with the risk of pre-eclampsia. | Duan W et al. | 2020 | Bioscience reports |
| 32403142 | Association of VEGF Gene Polymorphisms with Susceptibility to Diabetic Retinopathy: A Systematic Review and Meta-Analysis. | Yang Q et al. | 2020 | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme |
| 32478477 | HSPA1A gene polymorphism rs1008438 is associated with susceptibility to acute mountain sickness in Han Chinese individuals. | Liu Z et al. | 2020 | Molecular genetics & genomic medicine |
| 32585853 | Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia. | Ballester S et al. | 2020 | Genes |
| 32718338 | EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study. | Zhang JH et al. | 2020 | Military Medical Research |
| 32780457 | Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy. | Udagawa C et al. | 2020 | Cancer science |
| 32793663 | Interaction of two functional genetic variants LOXL1 rs1048661 and VEGFA rs3025039 on the risk of age-related macular degeneration in Chinese women. | Chen H et al. | 2020 | Annals of translational medicine |
| 32797194 | Genetic Variation and Hot Flashes: A Systematic Review. | Crandall CJ et al. | 2020 | The Journal of clinical endocrinology and metabolism |
| 32997825 | VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma. | Kaddu-Mulindwa D et al. | 2021 | European journal of haematology |
| 33260695 | Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes. | Balistreri CR et al. | 2020 | Genes |
| 33359674 | Polymorphisms in oxidative stress, metabolic detoxification, and immune function genes, maternal exposure to ambient air pollution, and risk of preterm birth in Taiyuan, China. | Zhao N et al. | 2021 | Environmental research |
| 33392836 | Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population. | Li Z et al. | 2021 | Breast cancer research and treatment |
| 33762959 | Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. | Sun F et al. | 2021 | Frontiers in pharmacology |
| 33922301 | Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease. | Remuzgo-Martínez S et al. | 2021 | Biomedicines |
| 34260629 | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. | Palmer BR et al. | 2021 | PloS one |
| 34346275 | The relationship of retinopathy of prematurity with brain-derivated neurotrophic factor, vascular endotelial growth factor-A, endothelial PAD domain protein 1 and nitric oxide synthase 3 gene polymorphisms. | Ilguy S et al. | 2021 | Ophthalmic genetics |
| 34440447 | Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes. | Villani L et al. | 2021 | Genes |
| 34494138 | Investigation of vascular endothelial growth factor (VEGF) polymorphism in patients with idiopathic heavy menstrual bleeding. | Kaygusuz I et al. | 2022 | Archives of gynecology and obstetrics |
| 34509102 | Association of specific single nucleotide variants (SNVs) in the promoter and 3'-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and higher tumour grade of head and neck cancers. | Ajaz S et al. | 2021 | Oral oncology |
| 34644732 | Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). | Carvalho SCR et al. | 2021 | Clinics (Sao Paulo, Brazil) |
| 34825587 | VEGF gene polymorphisms regulate human retinal vascular endothelial cell proliferation and apoptosis through ASF/SF2-associated alternative splicing. | Li H et al. | 2022 | European journal of ophthalmology |
| 34918882 | Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis. | Sertoglu E et al. | 2022 | Advances in clinical and experimental medicine |
| 34946296 | Increased Vascular Endothelial Growth Factor Serum Level and the Role of +936C/T Gene Polymorphism in Chronic Obstructive Pulmonary Disease. | Chis AF et al. | 2021 | Medicina (Kaunas, Lithuania) |
| 35030476 | Associations between AGT, MTHFR, and VEGF gene polymorphisms and preeclampsia in the Chinese population. | Ding G et al. | 2022 | Placenta |
| 35312415 | Quantile-specific heritability of serum growth factor concentrations. | Williams PT et al. | 2021 | Growth factors (Chur, Switzerland) |
| 35349405 | Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype. | Prieto-Peña D et al. | 2022 | Clinical and experimental rheumatology |
| 35365727 | Vascular endothelial growth factor (VEGF) polymorphism rs3025039 and atherosclerosis among older with hypertension. | Shimizu Y et al. | 2022 | Scientific reports |
| 35428537 | Association of VEGF-A and KDR polymorphisms with the development of schizophrenia. | Saoud H et al. | 2022 | Human immunology |
| 35629182 | Study of the Association between VEGF Polymorphisms and the Risk of Coronary Artery Disease in Koreans. | Ko EJ et al. | 2022 | Journal of personalized medicine |
| 35886018 | TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer. | Scola L et al. | 2022 | Genes |
| 35929944 | [Association of polymorphisms of VEGF and VEGFR1 pathways related genes and risk of pre-eclampsia]. | Li L et al. | 2022 | Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics |
| 35969320 | Association study of HIF-1α rs11549465 and VEGF rs3025039 genetic variants with diabetic retinopathy in Egyptian patients: crosslinks with angiogenic, inflammatory, and anti-inflammatory markers. | Mohamed MK et al. | 2022 | Journal, genetic engineering & biotechnology |
| 35996666 | The blunted vascular endothelial growth factor-A (VEGF-A) response to high-altitude hypoxia and genetic variants in the promoter region of the VEGFA gene in Sherpa highlanders. | Droma Y et al. | 2022 | PeerJ |
Help
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genome context:
Select flank length:
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.